SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Metamark Genetics, Inc. Completes $22 Million Series B Financing to Advance Pipeline of Innovative Function-Based Prognostic Assays for Early Stage Cancers